Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALNY vs GSK✓SelectedUSD · GSKALNY vs GSK performance historyLatest closeAs of-4.54%11/18
Stock and ETF performance explorer

ALNY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-34.6%
GSK return
-3.4%
Excess return
-31.2%
Maximum drawdown
-44.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.5%-1.3%-3.2%-3.9%
7D-6.5%-3.1%-3.4%-5.0%
30D-36.0%-0.9%-35.1%-36.1%
3M-34.6%-4.2%-30.5%-32.5%
All-34.6%-3.4%-31.2%-32.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3mo analysis · Full analysis span regression · Available span rolling